DigitalOcean Holdings Inc vs Guardant Health Inc. Common Stock — how do they compare? DigitalOcean Holdings Inc trades at $125.66 (market cap $14.57B), while Guardant Health Inc. Common Stock trades at $165.58 (market cap $22.22B). The key difference: Guardant Health Inc. Common Stock is the larger of the two by market cap, and Guardant Health Inc. Common Stock is trading nearer its 52-week high, DigitalOcean Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DigitalOcean Holdings Inc for 43 Days and Guardant Health Inc. Common Stock for 0 Days on average.
| DOCN | GH | |
|---|---|---|
Market Cap | $14.57B | $22.22B |
Volume | 2,261,786 | 1,589,453 |
Sector | Technology | Health |
52-Week High | $181.29 | $187.22 |
52-Week Low | $37.30 | $61.73 |
Typical Hold Time | 43 Days | 0 Days |
Enterprise Value | $15.33B | $22.86B |
Signals from Pluang's Aura AI — not financial advice
DigitalOcean trades at $127.28, down 2.89% today, with strong technical support at $126 and resistance at $130. The company shows robust revenue growth from $576M in 2022 to $901M in 2025, with net income turning positive to $259M. Recent AI-focused product launches including Agent Droplets and Managed Agents position the company for continued growth in cloud services.
Despite high valuation multiples (P/E 57.85, P/S 14.34), analyst consensus remains bullish with a $172.73 price target representing 36% upside. Key risks include capital intensity from expansion and high debt levels, while institutional accumulation and consistent earnings beats support the growth narrative.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.
Read more on DOCN →Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →